As lung cancer treatments evolve and more data are published, there is a need for updated recommendations on how to manage ...

Targeted therapies have changed non-small cell lung cancer care, but new side effects, like weight gain, are emerging, says Dr. Lorenzo Belluomini.

A guide for patients to understand HER2-positive breast cancer, treatment options by stage and how to talk with your oncologist.

A novel targeted radiation approach for a rare form of malignant tumor—the solitary fibrous tumor (SFT)—has shown significant ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

The current standard of care for advanced ROS1-positive NSCLC is the use of a ROS1 tyrosine kinase inhibitor (TKI), ideally in the first-line setting. Recently approved agents like talotrectinib are ...

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and ...

Dr Daniel Petrylak discusses groundbreaking advancements in prostate cancer treatment, including genetic mutations, PARP ...

Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the ...

The FDA has granted priority review to the supplemental biologics license application (sBLA) of fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the first-line treatment of patients with ...